Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Innate Pharma (IPHA) Asset Utilization Ratio (2022 - 2024)

Innate Pharma posted quarterly Asset Utilization Ratio of 0.83 for Q4 2024, down 7.47% year-on-year from 0.9 in Q1 2024, and down 10.14% on a QoQ basis from 0.92 in Q2 2024.

Innate Pharma (IPHA) has 3 years of Asset Utilization Ratio data on file, last reported at 0.83 in Q4 2024.

  • For the quarter ending Q4 2024, Asset Utilization Ratio fell 7.47% year-over-year to 0.83; the trailing twelve-month figure through Dec 2024 stood at 0.83 (down 7.47% YoY), and the FY2025 full-year result was 0.03, down 75.82% from the prior year.
  • Asset Utilization Ratio for Q4 2024 stood at 0.83, down from 0.92 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.92 in Q2 2024 and bottomed at 0.05 in Q2 2022.
  • The 3-year median for Asset Utilization Ratio is 0.9 (2023), against an average of 0.72.
  • The widest annual swing landed in 2023, when Asset Utilization Ratio jumped 1800.57%; it then fell 7.47% in 2024.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.05 in 2022, then surged by 1795.11% to 0.9 in 2023, then dropped by 7.47% to 0.83 in 2024.
  • The last three Asset Utilization Ratio figures came in at 0.83 (Q4 2024), 0.92 (Q2 2024), and 0.9 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 0.60
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 0.47
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 0.37
8 Evaxion A 65.44 Bn 65.42 Bn - 0.29
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 0.85
10 Innate Pharma 199.64 Mn 199.64 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 0.83
Jun 30, 2024 0.92
Dec 31, 2023 0.90
Jun 30, 2023 0.90
Jun 30, 2022 0.05